Subscribe To
cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street esti...
February 3, 2022, 7:47 am
cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street esti...
February 3, 2022, 7:47 am
cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street esti...
February 3, 2022, 7:47 am
cardinal health (cah) to post q2 earnings: what's in store?
cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Ph...
January 31, 2022, 1:06 pm
cardinal health (cah) to post q2 earnings: what's in store?
cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Ph...
January 31, 2022, 1:06 pm
cardinal health (cah) to post q2 earnings: what's in store?
cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Ph...
January 31, 2022, 1:06 pm
Ember expands into cold chain medical shipping with new device, cardinal health partnership
Last year, Ember outlined one of the more fascinating expansions of recent vintage we've seen in the hardware space. Primarily known for its smart mug...
January 31, 2022, 12:48 pm
Ember expands into cold chain medical shipping with new device, cardinal health partnership
Last year, Ember outlined one of the more fascinating expansions of recent vintage we've seen in the hardware space. Primarily known for its smart mug...
January 31, 2022, 12:48 pm
Ember expands into cold chain medical shipping with new device, cardinal health partnership
Last year, Ember outlined one of the more fascinating expansions of recent vintage we've seen in the hardware space. Primarily known for its smart mug...
January 31, 2022, 12:48 pm
Madrigal pharma's kidney disease candidate improves liver, cardiovascular health
Madrigal Pharmaceuticals Inc MDGL has announced topline data from Phase 3 MAESTRO-NAFLD-1 safety study of resmetirom. [ALERT] Nic Chahine shares ...
January 31, 2022, 8:46 am
Madrigal pharma's kidney disease candidate improves liver, cardiovascular health
Madrigal Pharmaceuticals Inc MDGL has announced topline data from Phase 3 MAESTRO-NAFLD-1 safety study of resmetirom. [ALERT] Nic Chahine shares ...
January 31, 2022, 8:46 am
Madrigal pharma's kidney disease candidate improves liver, cardiovascular health
Madrigal Pharmaceuticals Inc MDGL has announced topline data from Phase 3 MAESTRO-NAFLD-1 safety study of resmetirom. [ALERT] Nic Chahine shares ...
January 31, 2022, 8:46 am
Ionis, pfizer scrap plans for experimental cardiovascular drug
Shares of Ionis Pharmaceuticals Inc. IONS, +5.11% fell 7.9% in premarket trading on Monday after the company and Pfizer Inc. PFE, +1.80% said they dis...
January 31, 2022, 7:41 am
Ionis, pfizer scrap plans for experimental cardiovascular drug
Shares of Ionis Pharmaceuticals Inc. IONS, +5.11% fell 7.9% in premarket trading on Monday after the company and Pfizer Inc. PFE, +1.80% said they dis...
January 31, 2022, 7:41 am
Ionis, pfizer scrap plans for experimental cardiovascular drug
Shares of Ionis Pharmaceuticals Inc. IONS, +5.11% fell 7.9% in premarket trading on Monday after the company and Pfizer Inc. PFE, +1.80% said they dis...
January 31, 2022, 7:41 am
Capricor therapeutics, nippon shinyaku ink us pact for duchenne muscular dystrophy candidate
Capricor Therapeutics Inc (NASDAQ: CAPR) has partnered with Nippon Shinyaku Co Ltd for the exclusive commercialization and distribution in the U.S...
January 25, 2022, 11:06 am
Capricor therapeutics, nippon shinyaku ink us pact for duchenne muscular dystrophy candidate
Capricor Therapeutics Inc (NASDAQ: CAPR) has partnered with Nippon Shinyaku Co Ltd for the exclusive commercialization and distribution in the U.S...
January 25, 2022, 11:06 am
Capricor therapeutics, nippon shinyaku ink us pact for duchenne muscular dystrophy candidate
Capricor Therapeutics Inc (NASDAQ: CAPR) has partnered with Nippon Shinyaku Co Ltd for the exclusive commercialization and distribution in the U.S...
January 25, 2022, 11:06 am
Ionis' eplontersen receives fda orphan drug status for misfolded protein disorder
The FDA has granted orphan drug designation to Ionis Pharmaceuticals Inc's (NASDAQ: IONS) eplontersen, an investigational antisense medicine for t...
January 24, 2022, 9:25 am
Ionis' eplontersen receives fda orphan drug status for misfolded protein disorder
The FDA has granted orphan drug designation to Ionis Pharmaceuticals Inc's (NASDAQ: IONS) eplontersen, an investigational antisense medicine for t...
January 24, 2022, 9:25 am